Lewis V. Buchanan

683 total citations
21 papers, 540 citations indexed

About

Lewis V. Buchanan is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Lewis V. Buchanan has authored 21 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Lewis V. Buchanan's work include Cardiac electrophysiology and arrhythmias (11 papers), Cardiac Arrhythmias and Treatments (9 papers) and Cardiac pacing and defibrillation studies (7 papers). Lewis V. Buchanan is often cited by papers focused on Cardiac electrophysiology and arrhythmias (11 papers), Cardiac Arrhythmias and Treatments (9 papers) and Cardiac pacing and defibrillation studies (7 papers). Lewis V. Buchanan collaborates with scholars based in United States and Germany. Lewis V. Buchanan's co-authors include John K. Gibson, Glenn Kabell, Marshall N. Brunden, John K. Gibson, Henry H. Holzgrefe, Luiz Belardinelli, Michael Gill, Stephen K. Durham, Icilio Cavero and Charles W. Ford and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Lewis V. Buchanan

21 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lewis V. Buchanan United States	13	331	177	94	45	45	21	540
J. Broekhuysen Belgium	14	316 1.0×	204 1.2×	62 0.7×	59 1.3×	39 0.9×	26	683
Pekka Ottoila Finland	12	154 0.5×	82 0.5×	30 0.3×	64 1.4×	25 0.6×	19	506
M. Sch�fer-Korting Germany	13	82 0.2×	104 0.6×	22 0.2×	53 1.2×	16 0.4×	19	523
Alice Wells United States	15	62 0.2×	166 0.9×	32 0.3×	85 1.9×	11 0.2×	43	568
Jovanka Kolarović Serbia	7	56 0.2×	69 0.4×	65 0.7×	26 0.6×	38 0.8×	19	373
Morris Pfeffer United States	14	51 0.2×	97 0.5×	36 0.4×	206 4.6×	16 0.4×	20	634
John F. Pauls United States	8	989 3.0×	271 1.5×	14 0.1×	63 1.4×	28 0.6×	13	1.2k
Heidi Ligeret France	6	30 0.1×	184 1.0×	26 0.3×	35 0.8×	40 0.9×	9	380
Seiko Hattori Japan	15	180 0.5×	246 1.4×	35 0.4×	170 3.8×	40 0.9×	26	653
F A deLuna United States	15	52 0.2×	164 0.9×	218 2.3×	130 2.9×	8 0.2×	24	844

Countries citing papers authored by Lewis V. Buchanan

Since Specialization

Citations

This map shows the geographic impact of Lewis V. Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis V. Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis V. Buchanan more than expected).

Fields of papers citing papers by Lewis V. Buchanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis V. Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis V. Buchanan. The network helps show where Lewis V. Buchanan may publish in the future.

Co-authorship network of co-authors of Lewis V. Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis V. Buchanan. A scholar is included among the top collaborators of Lewis V. Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis V. Buchanan. Lewis V. Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buchanan, Lewis V., et al.. (2016). Evaluation of cardiac function in unrestrained dogs and monkeys using left ventricular dP/dt. Journal of Pharmacological and Toxicological Methods. 80. 51–58. 5 indexed citations

Buchanan, Lewis V., et al.. (2015). Assessment of cardiac function in large animal telemetry studies: Model sensitivity and historical results. Journal of Pharmacological and Toxicological Methods. 75. 178–178. 1 indexed citations

Holzgrefe, Henry H., Icilio Cavero, Lewis V. Buchanan, Michael Gill, & Stephen K. Durham. (2006). Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: Effects of moxifloxacin. Journal of Pharmacological and Toxicological Methods. 55(3). 244–254. 45 indexed citations

Holzgrefe, Henry H., Icilio Cavero, Carol Gleason, et al.. (2006). Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys. Journal of Pharmacological and Toxicological Methods. 55(2). 159–175. 40 indexed citations

Buchanan, Lewis V., et al.. (2004). Effects of linezolid on staphylococcal adherence versus time of treatment. International Journal of Antimicrobial Agents. 23(3). 226–234. 17 indexed citations

Buchanan, Lewis V., et al.. (2003). Efficacy of Linezolid plus Rifampin in an Experimental Model of Methicillin-Susceptible Staphylococcus aureus Endocarditis. Antimicrobial Agents and Chemotherapy. 47(8). 2655–2658. 32 indexed citations

Hester, Jackson B., John K. Gibson, Lewis V. Buchanan, et al.. (2001). Progress toward the Development of a Safe and Effective Agent for Treating Reentrant Cardiac Arrhythmias: Synthesis and Evaluation of Ibutilide Analogues with Enhanced Metabolic Stability and Diminished Proarrhythmic Potential. Journal of Medicinal Chemistry. 44(7). 1099–1115. 18 indexed citations

Buchanan, Lewis V., et al.. (2001). Efficacy of Linezolid in Treatment of Experimental Endocarditis Caused by Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 45(8). 2304–2308. 61 indexed citations

Higdon, Nicole R., Sajida Khan, Lewis V. Buchanan, & Kaushik D. Meisheri. (1997). Tissue and species variation in the vascular receptor binding of 3H-P1075, a potent KATP opener vasodilator.. PubMed. 280(1). 255–60. 8 indexed citations

10.

Higdon, Nicole R., Sajida Khan, Lewis V. Buchanan, & Kaushik D. Meisheri. (1997). Tissue and Species Variation in the Vascular Receptor Binding of3H-P1075, a Potent KATP Opener Vasodilator. Journal of Pharmacology and Experimental Therapeutics. 280(1). 255–260. 4 indexed citations

11.

Buchanan, Lewis V., et al.. (1996). Antiarrhythmic and Electrophysiologic Effects of Intravenous Ibutilide and Sotaloi in the Canine Sterile Pericarditis Model. Journal of Cardiovascular Electrophysiology. 7(2). 113–119. 21 indexed citations

12.

Buchanan, Lewis V., Glenn Kabell, & John K. Gibson. (1995). Acute Intravenous Conversion of Canine Atrial Flutter. Journal of Cardiovascular Pharmacology. 25(4). 539–544. 18 indexed citations

13.

Buchanan, Lewis V., et al.. (1995). Antiarrhythmic and electrophysiologic effects of sublingual ibutilide fumarate. Drug Development Research. 34(4). 322–328. 5 indexed citations

14.

Toombs, Christopher F., Sajida Khan, Lewis V. Buchanan, et al.. (1994). Comparative Effects of the Potassium Channel Openers Cromakalim and Pinacidil and the Cromakalim Analog U-89232 on Isolated Vascular and Cardiac Tissue. Pharmacology. 49(2). 86–95. 12 indexed citations

15.

Kabell, Glenn, Lewis V. Buchanan, John K. Gibson, & Luiz Belardinelli. (1994). Effects of adenosine on atrial refractoriness and arrhythmias. Cardiovascular Research. 28(9). 1385–1389. 61 indexed citations

16.

Buchanan, Lewis V., et al.. (1993). Effects of artilide on spontaneous and induced ventricular arrhythmias in 24‐hour canine myocardial infarction. Drug Development Research. 30(1). 30–36. 3 indexed citations

17.

Buchanan, Lewis V., et al.. (1993). Antiarrhythmic and Electrophysiologic Effects of Ibutilide in a Chronic Canine Model of Atrial Flutter. Journal of Cardiovascular Pharmacology. 22(1). 10–14. 39 indexed citations

18.

Buchanan, Lewis V., Glenn Kabell, Marshall N. Brunden, & John K. Gibson. (1993). Comparative Assessment of Ibutilide, D-Sotalol, Clofilium, E-4031, and UK-68, 798 in a Rabbit Model of Proarrhythmia. Journal of Cardiovascular Pharmacology. 22(4). 220–549. 83 indexed citations

19.

Buchanan, Lewis V., et al.. (1992). Effects of Ibutilide on Spontaneous and Induced Ventricular Arrhythmias in 24-Hour Canine Myocardial Infarction. Journal of Cardiovascular Pharmacology. 19(2). 256–263. 36 indexed citations

20.

Holzgrefe, Henry H., Lewis V. Buchanan, & John K. Gibson. (1990). Effects of U74006F, a Novel Inhibitor of Lipid Peroxidation, in Stunned Reperfused Canine Myocardium. Journal of Cardiovascular Pharmacology. 15(2). 239–248. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact